About
Nordic Nanovector AS is a biopharmaceutical company focused on developing targeted therapies, including antibody-drug conjugates, for the treatment of hematological cancers such as blood cancers.
Explore Nordic Nanovector AS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.